2012 ESMO临床实践指南:结直肠癌

2012-10-02 MedSci MedSci原创

2012ESMO结直肠癌诊治指南新鲜出炉! Annals of Oncology 9月27日在线发表,值得一读。备受关注的奥沙利铂与西妥昔单抗联合问题,ESMO指南虽说要慎重选择化疗方案,但依然推荐与FOLFOX联合,只是不推荐与CapeOx或FLOX方案联。 ESMO Consensus Guidelines for management of patients with colon and

2012ESMO结直肠癌诊治指南新鲜出炉! Annals of Oncology 9月27日在线发表,值得一读。备受关注的奥沙利铂与西妥昔单抗联合问题,ESMO指南虽说要慎重选择化疗方案,但依然推荐与FOLFOX联合,只是不推荐与CapeOx或FLOX方案联。

ESMO Consensus Guidelines for management of patients with colon and rectal cancer.pdf

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2030967, encodeId=a42d203096eb8, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Aug 12 22:59:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024674, encodeId=a10320246e4dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Fri Jul 12 22:59:00 CST 2013, time=2013-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323586, encodeId=5b75132358676, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452601, encodeId=1652145260186, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571917, encodeId=072515e1917f7, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2030967, encodeId=a42d203096eb8, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Aug 12 22:59:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024674, encodeId=a10320246e4dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Fri Jul 12 22:59:00 CST 2013, time=2013-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323586, encodeId=5b75132358676, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452601, encodeId=1652145260186, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571917, encodeId=072515e1917f7, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
    2013-07-12 liuhuangbo
  3. [GetPortalCommentsPageByObjectIdResponse(id=2030967, encodeId=a42d203096eb8, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Aug 12 22:59:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024674, encodeId=a10320246e4dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Fri Jul 12 22:59:00 CST 2013, time=2013-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323586, encodeId=5b75132358676, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452601, encodeId=1652145260186, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571917, encodeId=072515e1917f7, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
    2012-10-04 zhang92560
  4. [GetPortalCommentsPageByObjectIdResponse(id=2030967, encodeId=a42d203096eb8, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Aug 12 22:59:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024674, encodeId=a10320246e4dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Fri Jul 12 22:59:00 CST 2013, time=2013-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323586, encodeId=5b75132358676, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452601, encodeId=1652145260186, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571917, encodeId=072515e1917f7, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2030967, encodeId=a42d203096eb8, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Aug 12 22:59:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024674, encodeId=a10320246e4dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Fri Jul 12 22:59:00 CST 2013, time=2013-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323586, encodeId=5b75132358676, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452601, encodeId=1652145260186, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571917, encodeId=072515e1917f7, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2030967, encodeId=a42d203096eb8, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Aug 12 22:59:00 CST 2013, time=2013-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024674, encodeId=a10320246e4dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Fri Jul 12 22:59:00 CST 2013, time=2013-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323586, encodeId=5b75132358676, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452601, encodeId=1652145260186, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571917, encodeId=072515e1917f7, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Oct 04 13:59:00 CST 2012, time=2012-10-04, status=1, ipAttribution=)]

相关资讯

T2DM控制现状与指南尚有很大差距

  北京大学人民医院纪立农和北京大学护理学院孟朝琳、李明子对北京市三甲医院2型糖尿病(T2DM)控制现状进行了调查分析,结果发现,北京市三甲医院T2DM控制现状有所改善,但与指南比较还有很大差距。研究发表于2012 年第4期《中国糖尿病杂志》。   研究者们在北京市6家三甲医院中选择1151例T2DM患者作为研究对象,通过访谈、查阅病例和电子临床检验系统等方法收集信息,以2007年版《

美国痔诊断和治疗指南(中文版)

 美国结直肠外科医师协会标准化工作委员会旨在引领国际结直肠肛门疾病的最佳诊断和治疗方案的制订,并建立具有循证医学证据的临床指南。该指南为临床医务工作者提供了相关的诊断和治疗方案,具有重要的指导意义。该指南(中文版)发表在2012年6月《中华消化外科杂志》[2012,11(3):243]。医学论坛网编辑简摘如下:    诊断和检查:   1) 初步诊断:痔的诊断主要依靠临床症状和体征。

房颤快速复律的新星-Vernakalant--聚焦ESC2012 心房颤动治疗指南更新

    Vemakalant是一种选择性心房离子通道混合性钠/钾通道阻滞剂,通过延长心房不应期,阻滞速率依赖性的离子通道,延长心房传导,但对心室复极没有显著影响。该药物在人体中起效迅速,半衰期3-5h。在2010年ESC指南公布后,Vernakalant已获准用于AF持续≤7天的非手术患者,或心脏外科手术后发生AF持续≤3天的患者快速转复窦律。关于Vernakalan

房颤的导管消融治疗,证据级别、推荐等级全线升级——聚焦ESC2012 心房颤动治疗指南更新

自2010年ESC房颤管理指南公布以来,越来越多的与房颤导管消融治疗相关的研究被发表报道,包括多项随机或非随机研究,单中心或多中心研究。这些研究带来对房颤导管消融的新认识,最终促成了房颤指南的更新,使导管消融治疗的证据级别、推荐等级全线升级。 导管消融治疗的新证据支持全线升级房颤导管消融治疗的推荐等级 随着多项随机与非随机研究发表,房颤的导管消融治疗显示出了较抗心律失常药物在维持窦律、改善生活质量

童南伟:糖尿病领域重要的临床进展

   前言:在过去的2011年,国际糖尿病联盟(IDF)、美国内分泌医师协会(AACE)、中华医学会糖尿病学分会及内分泌学分会等组织,针对糖尿病的临床诊治、实验室检测及并发症的治疗等颁布了一些指南和共识;关于中国人糖尿病血管病变特点及糖尿病死因方面也有心得研究发布;同时,对于几种降糖药物的安全性问题,美国食品与药品管理局(FDA)和欧洲药品管理委员会(EMEA)也发布了声明。这些对于规范

《临床试验数据管理工作技术指南》发布(可下载)

 临床试验数据是支持药品获准上市的最重要实证。良好规范的数据管理工作是保证临床试验质量的关键。我国《药品注册管理办法》和《药物临床试验质量管理规范》等对此均有相应的原则性要求。在技术操作层面还需要相应细化的技术指南。      为加强我国药物临床试验数据的规范管理,保证药物临床研究数据的质量,使药物的评价基于科学的实证,自2009年以来,